Hemond Christopher C, Dundamadappa Sathish K, Deshpande Mugdha, Baek Jonggyu, Brown Robert H, Ionete Carolina, Reich Daniel S
Department of Neurology, University of Massachusetts Memorial Medical Center, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Brain Commun. 2025 May 29;7(3):fcaf211. doi: 10.1093/braincomms/fcaf211. eCollection 2025.
Paramagnetic rim lesions (PRLs) are an emerging biomarker for multiple sclerosis representing chronic, low-grade intraparenchymal brain inflammation. In addition to associating with greater disease severity, PRLs may be diagnostically supportive. Our aim in this study was to determine PRL specificity and sensitivity for discriminating multiple sclerosis from its diagnostic mimics using real-world clinical diagnostic and imaging data. This is a retrospective, cross-sectional analysis of a longitudinal cohort of patients with prospectively collected observational data. Patients were included if they underwent clinical evaluation in our academic neuroimmunology centre and had an available MRI scan from the same clinical 3-T magnet that included a T2*-weighted sequence with susceptibility post-processing (Susceptibility Weighted ANgiography protocol, General Electric). Susceptibility imaging-derived filtered phase maps and corresponding T2-fluid attenuated inversion recovery images were manually reviewed to determine PRLs. PRLs were categorized as 'definite', 'probable' or 'possible' based on modified, recent consensus criteria. We hypothesized that PRLs would convey a high specificity to discriminate multiple sclerosis from its MRI mimics. Five hundred seventy-four patients were evaluated in total: 473 with multiple sclerosis, 53 with non-inflammatory neurological disease and 48 with other inflammatory neurological disease. Identification of 'definite' or 'probable' PRL provided a specificity of 98% to discriminate multiple sclerosis from non-inflammatory neurological disease and other inflammatory neurological disease; sensitivity was 36%. Interrater agreement was almost perfect for definite/probable identification at a subject level. PRLs convey high specificity for multiple sclerosis and can aid in the diagnostic evaluation. Modest sensitivity limits their use as single diagnostic indicators. Including lesions with lower confidence ('possible') rapidly erodes specificity and should be interpreted with caution given the potential harms associated with misdiagnosis.
顺磁性边缘病变(PRLs)是一种新兴的多发性硬化生物标志物,代表慢性、低度脑实质内炎症。除了与更严重的疾病相关外,PRLs可能具有诊断支持作用。我们在本研究中的目的是利用真实世界的临床诊断和影像数据,确定PRLs在鉴别多发性硬化与其诊断模仿疾病方面的特异性和敏感性。这是一项对具有前瞻性收集的观察数据的纵向队列进行的回顾性横断面分析。如果患者在我们的学术神经免疫学中心接受了临床评估,并且有来自同一台临床3-T磁共振成像仪的可用扫描图像,其中包括经过磁化率后处理的T2*加权序列(通用电气公司的磁化率加权血管造影协议),则纳入研究。对磁化率成像衍生的滤波相位图和相应的T2液体衰减反转恢复图像进行人工检查以确定PRLs。根据修改后的最新共识标准,PRLs被分类为“确定”、“很可能”或“可能”。我们假设PRLs在鉴别多发性硬化与其磁共振成像模仿疾病方面具有高特异性。总共评估了574名患者:473名患有多发性硬化,53名患有非炎性神经系统疾病,48名患有其他炎性神经系统疾病。识别“确定”或“很可能”的PRLs在鉴别多发性硬化与非炎性神经系统疾病和其他炎性神经系统疾病方面的特异性为98%;敏感性为36%。在个体水平上,对于确定/很可能的识别,观察者间一致性几乎完美。PRLs对多发性硬化具有高特异性,可有助于诊断评估。适度的敏感性限制了它们作为单一诊断指标的使用。纳入可信度较低的病变(“可能”)会迅速降低特异性,鉴于与误诊相关的潜在危害,应谨慎解释。